<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmacy (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Pharmacy (Basel)</journal-id><journal-id journal-id-type="publisher-id">pharmacy</journal-id><journal-title-group><journal-title>Pharmacy</journal-title></journal-title-group><issn pub-type="epub">2226-4787</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998028</article-id><article-id pub-id-type="pmc">PMC11859786</article-id>
<article-id pub-id-type="doi">10.3390/pharmacy13010030</article-id><article-id pub-id-type="publisher-id">pharmacy-13-00030</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Pilot Study Evaluating the Impact of an Algorithm-Driven Protocol on Guideline-Concordant Antibiotic Prescribing in a Rural Primary Care Setting</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1956-5162</contrib-id><name><surname>Nkemdirim Okere</surname><given-names>Arinze</given-names></name><xref rid="af1-pharmacy-13-00030" ref-type="aff">1</xref><xref rid="c1-pharmacy-13-00030" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Pinto</surname><given-names>Anthony Ryan</given-names></name><xref rid="af2-pharmacy-13-00030" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6440-3974</contrib-id><name><surname>Suther</surname><given-names>Sandra</given-names></name><xref rid="af3-pharmacy-13-00030" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5041-0708</contrib-id><name><surname>Ten Eyck</surname><given-names>Patrick</given-names></name><xref rid="af4-pharmacy-13-00030" ref-type="aff">4</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Al-Hasan</surname><given-names>Majdi N.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Modun</surname><given-names>Darko</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pharmacy-13-00030"><label>1</label>College of Pharmacy, The University of Iowa, 180 South Grand Ave, 366B College of Pharmacy Building, Iowa City, IA 52242, USA</aff><aff id="af2-pharmacy-13-00030"><label>2</label>Community Health Northwest Florida Community-Based Pharmacy Residency Program, Florida A&#x00026;M University, 2315 W Jackson St, Pensacola, FL 32505, USA; <email>anthony.pinto@famu.edu</email></aff><aff id="af3-pharmacy-13-00030"><label>3</label>College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&#x00026;M University, 1415 Martin Luther King Jr. BLVD, Tallahassee, FL 32307, USA; <email>sandra.suther@famu.edu</email></aff><aff id="af4-pharmacy-13-00030"><label>4</label>Institute for Clinical and Translational Science, Department of Biostatistics, University of Iowa, 200 Hawkins Drive, SW44-M GH, Iowa City, IA 52246, USA; <email>patrick-teneyck@uiowa.edu</email></aff><author-notes><corresp id="c1-pharmacy-13-00030"><label>*</label>Correspondence: <email>arinzechukwu-okere@uiowa.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>1</issue><elocation-id>30</elocation-id><history><date date-type="received"><day>30</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>29</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>17</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Approximately 2.8 million cases of bacterial antimicrobial resistance (AMR) infections result in over 35,000 deaths annually in the U.S. AMR is driven largely by inappropriate prescribing of antibiotics, especially in clinics serving rural communities or underserved populations. Antibiotic Stewardship Programs (ASPs) improve prescribing practices, but many rural clinics lack fully functional ASPs. This pilot study evaluated the impact of an algorithm-driven protocol on antibiotic prescribing in a rural primary care setting. We conducted a pre&#x02013;post quasi-experimental study at a Federally Qualified Health Center (FQHC), focusing on upper respiratory infections, urinary tract infections, and sexually transmitted infections. Eligible patients were enrolled in the study during their primary care visits. The primary outcome was the frequency of guideline-concordant treatment, analyzed using descriptive statistics and Chi-square tests. Among 201 patients (101 pre-intervention, 100 post-intervention), the pre-intervention group consisted of 77% females and 47% African Americans, while the post-intervention group consisted of 72% females and 46% African Americans. The intervention was associated with a 12.6% decrease in the number of antibiotic prescriptions discordant with clinical guidelines (37.6% to 25%) from the pre- to post-intervention periods. This corresponded to an odds ratio of 0.55 (95% CI: 0.30&#x02013;1.01, <italic toggle="yes">p</italic> = 0.054). Although not statistically significant at &#x003b1; = 0.05, this numerical decrease suggests potential benefits of algorithm-driven protocols in improving antibiotic stewardship in resource-limited settings. Longer study periods may further elucidate these benefits.</p></abstract><kwd-group><kwd>antibiotic stewardship program</kwd><kwd>rural health</kwd><kwd>underserved population</kwd><kwd>antibiotics</kwd><kwd>pharmacy</kwd></kwd-group><funding-group><award-group><funding-source>American Society of Heath-System Pharmacists (ASHP) foundation</funding-source></award-group><award-group><funding-source>American Association of Colleges of Pharmacy (AACP) foundation</funding-source></award-group><award-group><funding-source>National Center for Advancing Translational Sciences of the National Institutes of Health</funding-source><award-id>UM1TR004403</award-id></award-group><funding-statement>The study was supported by the American Society of Heath-System Pharmacists (ASHP) foundation and the American Association of Colleges of Pharmacy (AACP) foundation. Additionally, research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UM1TR004403. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmacy-13-00030"><title>1. Introduction</title><p>Each year in the United States, approximately 2.8 million cases of antimicrobial-resistant bacterial infections result in over 35,000 deaths [<xref rid="B1-pharmacy-13-00030" ref-type="bibr">1</xref>]. A significant driver of antimicrobial resistance (AMR) is the inappropriate prescribing of antibiotics, particularly in outpatient settings, where over 50% of prescriptions are deemed unnecessary or inappropriate [<xref rid="B2-pharmacy-13-00030" ref-type="bibr">2</xref>,<xref rid="B3-pharmacy-13-00030" ref-type="bibr">3</xref>,<xref rid="B4-pharmacy-13-00030" ref-type="bibr">4</xref>]. This issue is especially pronounced in clinics serving rural or underserved populations [<xref rid="B5-pharmacy-13-00030" ref-type="bibr">5</xref>,<xref rid="B6-pharmacy-13-00030" ref-type="bibr">6</xref>].</p><p>Fortunately, antibiotic stewardship programs (ASPs) have been shown to significantly improve antibiotic prescribing [<xref rid="B7-pharmacy-13-00030" ref-type="bibr">7</xref>,<xref rid="B8-pharmacy-13-00030" ref-type="bibr">8</xref>,<xref rid="B9-pharmacy-13-00030" ref-type="bibr">9</xref>], yet they remain largely absent in clinics serving rural communities or underserved populations. Despite the Centers for Disease Control and Prevention (CDC) recognizing inappropriate antibiotic prescribing as a significant issue in these communities&#x02014;contributing to antimicrobial resistance (AMR) and <italic toggle="yes">Clostridioides difficile</italic> infections&#x02014;the full extent of the problem remains inadequately understood [<xref rid="B10-pharmacy-13-00030" ref-type="bibr">10</xref>]. A 2020 survey of Vizient member hospitals found that while 88% of inpatient institutions had functional ASPs, only 7% of ambulatory practices implemented them, most of which were in urban areas [<xref rid="B11-pharmacy-13-00030" ref-type="bibr">11</xref>]. Given the limited healthcare access and resources in rural settings, the prevalence of ASPs in these communities is likely even lower. This gap highlights the urgent need for targeted strategies to curb antibiotic misuse and overuse in rural and underserved populations.</p><p>Several randomized controlled trials have demonstrated that strategies such as point-of-care testing, communication skills training, clinical decision support, and individualized audit-and-feedback for providers can effectively reduce unnecessary antibiotic use in primary care clinics [<xref rid="B12-pharmacy-13-00030" ref-type="bibr">12</xref>,<xref rid="B13-pharmacy-13-00030" ref-type="bibr">13</xref>,<xref rid="B14-pharmacy-13-00030" ref-type="bibr">14</xref>,<xref rid="B15-pharmacy-13-00030" ref-type="bibr">15</xref>,<xref rid="B16-pharmacy-13-00030" ref-type="bibr">16</xref>]. However, these strategies often require substantial technical resources that may not be readily available or sustainable in resource-limited settings, such as clinics serving rural communities or underserved populations. Understanding these challenges is crucial to developing feasible and effective antimicrobial stewardship programs (ASPs) tailored to these environments.</p><p>To gain insight into the perspectives of both patients and clinicians regarding the implementation of ASPs in such settings, we conducted a survey study in a primary care center serving rural communities and underserved populations. The findings revealed that both patients and healthcare providers expressed openness to the integration of ASPs, highlighting a willingness to adopt stewardship initiatives despite existing resource constraints [<xref rid="B17-pharmacy-13-00030" ref-type="bibr">17</xref>,<xref rid="B18-pharmacy-13-00030" ref-type="bibr">18</xref>]. Furthermore, as part of this endeavor to improve antibiotic prescribing in resource-limited clinics, we evaluated the impact of integrating pharmacist-led medication therapy management with an ASP in a resource-limited clinic. The study revealed a 63.69% reduction in antibiotic prescriptions per 1000 patients over several weeks, suggesting that a pharmacist-led ASP is associated with a significant reduction in antibiotic use in a primary care center serving patients residing in rural or underserved communities. However, a limitation of the study is its pre&#x02013;post design, which may limit the ability to establish causality [<xref rid="B19-pharmacy-13-00030" ref-type="bibr">19</xref>].</p><p>Building on findings from our prior studies and acknowledging the resource constraints faced by rural clinics, we hypothesized that a low-tech approach&#x02014;specifically, a simplified algorithm-driven antibiotic protocol&#x02014;could effectively improve antibiotic prescribing practices in rural or underserved settings.</p><p>Thus, the objective of our pilot study was to evaluate the impact of an algorithm-driven protocol on antibiotic prescribing in a clinic serving rural or underserved communities.</p></sec><sec sec-type="methods" id="sec2-pharmacy-13-00030"><title>2. Methods</title><sec id="sec2dot1-pharmacy-13-00030"><title>2.1. Study Design</title><p>This was a pre&#x02013;post, quasi-experimental study aimed at evaluating antibiotic prescribing practices in a rural healthcare setting. We developed and implemented an algorithm targeting the most prevalent infectious diseases observed in our Federally Qualified Health Center (FQHC): upper respiratory infections (URIs), urinary tract infections (UTIs), and sexually transmitted infections (STIs). Due to the significant challenges and ethical concerns associated with conducting randomized clinical trials in rural or underserved communities&#x02014;particularly the ethical dilemmas of withholding potentially beneficial intervention from a control group in resource-limited settings&#x02014;a pre&#x02013;post design was chosen for this study to ensure that all eligible participants had access to the intervention. This study was approved by the Florida A&#x00026;M University Institutional Review Board (IRB).</p><p>Data collection for the pre-intervention period was conducted from November 2023 to January 2024, while the post-intervention period occurred from March 2024 to May 2024, coinciding with patient visits. To ensure that individual patients were not re-enrolled during multiple visits, the medical record numbers of all enrolled patients were documented for both the pre- and post-intervention periods. This approach maintained the integrity of the dataset by preventing duplicate entries.</p></sec><sec id="sec2dot2-pharmacy-13-00030"><title>2.2. Setting and Prior Intervention</title><p>The study was conducted at a major local healthcare clinic designated as a Federally Qualified Health Center (FQHC). These federally funded, nonprofit health centers serve medically underserved populations, providing care on a sliding fee scale based on financial need. In 2023, the clinic served 53,824 patients, accounting for approximately 120,818 medical visits. Of these, 56% were covered by Medicaid, 20% were uninsured, 16% had private insurance, and 7% were enrolled in Medicare.</p><p>The clinic collaborates with four community pharmacies, all of which participate in the 340B program, ensuring access to affordable medications. Additionally, these pharmacies offer pharmacist-led home health services accredited by the Accreditation Association for Ambulatory Health Care (AAAHC) and provide telehealth services. At the time of the study, the clinic lacked an established antibiotic stewardship program (ASP).</p></sec><sec id="sec2dot3-pharmacy-13-00030"><title>2.3. Intervention</title><p>The intervention consisted of educational sessions for all healthcare providers, focusing on antibiotic stewardship and the implications of antibiotic resistance, using guidelines and materials provided by the Centers for Disease Control and Prevention (CDC). This educational session was conducted by a pharmacy resident under the supervision of a clinical pharmacist. A simplified antibiotic prescribing algorithm was developed based on Infectious Diseases Society of America (IDSA) and CDC-recommended strategies for the management of URIs, UTIs, and STIs (see <xref rid="app1-pharmacy-13-00030" ref-type="app">Supplementary Materials</xref> for the simplified algorithm). This algorithm emphasized appropriate dosing, frequency, and duration and was distributed to all providers to encourage adherence to evidence-based prescribing practices.</p></sec><sec id="sec2dot4-pharmacy-13-00030"><title>2.4. Study Population</title><p>The study included adult patients at least 18 years old who presented with symptoms consistent with infectious diseases, such as fever, cough, or dyspnea, and who were diagnosed by primary care providers with upper respiratory infections (URIs), urinary tract infections (UTIs), or sexually transmitted infections (STIs). Pediatric patients under the age of 18 were excluded from the analysis, although care was provided to these patients during the study period.</p></sec><sec id="sec2dot5-pharmacy-13-00030"><title>2.5. Enrollment</title><p>Patients who met the inclusion and exclusion criteria were identified during their primary care visits. During these clinic visits, a pharmacy resident informed eligible participants about the study at the time of enrollment and obtained verbal consent. However, patients were not informed whether they belonged to the pre-intervention or post-intervention group. Data were collected for both the pre- and post-intervention periods.</p></sec><sec id="sec2dot6-pharmacy-13-00030"><title>2.6. Outcomes</title><p>The primary outcome of the study was to evaluate the change in the proportion of patients receiving guideline-concordant antibiotic prescriptions before and after the intervention. For this study, &#x0201c;guideline-concordant treatment&#x0201d; was defined as adherence to IDSA or CDC-recommended dosing strategies, including appropriate therapy duration, dosing frequency, and strength. Non-concordance was characterized by any deviations in these parameters. Diagnoses were further categorized into UTI, URI, and STI groups for analysis.</p></sec><sec id="sec2dot7-pharmacy-13-00030"><title>2.7. Data Collection</title><p>To assess the impact of the intervention, patient demographics, diagnoses, and prescription details were recorded in an Excel database. For each prescription, we documented the dose (strength), frequency, and duration. To further evaluate prescribing accuracy, prescription concordance was assessed in relation to patients&#x02019; renal function and documented allergies. Data were collected during the pre- and post-intervention periods to evaluate changes in antibiotic prescribing patterns and identify potentially inappropriate prescriptions. Of note, in this study, neither the researchers nor the pharmacy resident assessed the accuracy of the diagnoses. Instead, all prescription evaluations were based solely on the diagnoses documented in the electronic health record by the prescribing clinician.</p></sec><sec id="sec2dot8-pharmacy-13-00030"><title>2.8. Statistical Analysis</title><p>To assess the impact of the intervention, antibiotic prescriptions for eligible patients during the post-intervention period were compared to those for eligible patients during the pre-intervention period. Descriptive statistics were reported as counts and percentages to summarize patient demographics at the time of their primary care visits. To assess whether the intervention was associated with a significant change in guideline-concordant antibiotic prescribing, a Chi-square test for independence was conducted. This test compared the proportions of guideline-concordant prescriptions between the pre- and post-intervention periods, as these groups were independent. The odds ratio and 95% confidence interval for potentially inappropriate antibiotic prescriptions will be reported comparing pre- and post-intervention periods. A priori, statistical significance was defined as <italic toggle="yes">p</italic> &#x0003c; 0.05 using a two-tailed test. This analysis was conducted with IBM SPSS Statistics version 29.0.2.0 (20).</p></sec></sec><sec sec-type="results" id="sec3-pharmacy-13-00030"><title>3. Results</title><p>A total of 201 patients participated in this pilot study, with 101 patients in the pre-intervention group and 100 patients in the post-intervention group. Among those in the pre-intervention group, 77% of the participants were female, compared to 72% in the post-intervention group. Regarding racial demographics, 47% of the pre-intervention group identified as African American, and 41% identified as White. In the post-intervention group, 46% were African American, and 33% were White. Additional demographic details are presented in <xref rid="pharmacy-13-00030-t001" ref-type="table">Table 1</xref>.</p><p>Following the intervention, the proportion of patients receiving potentially inaccurate antibiotic prescriptions&#x02014;defined as deviations from guideline-concordant recommendations&#x02014;decreased by 12.6%, from 37.6% in the pre-intervention group to 25.0% in the post-intervention group. Chi-square analysis indicated a numerical decrease approaching statistical significance (&#x003c7;<sup>2</sup> = 3.72, <italic toggle="yes">p</italic> = 0.054). The odds ratio (OR) from pre- to post-intervention periods was 0.55 (95% CI: 0.30&#x02013;1.01). <xref rid="pharmacy-13-00030-t002" ref-type="table">Table 2</xref> presents all types of errors categorized by the type of infectious disease.</p></sec><sec sec-type="discussion" id="sec4-pharmacy-13-00030"><title>4. Discussion</title><p>In this pilot study, we observed the potential benefits of implementing an algorithm-driven protocol to improve antibiotic prescribing in clinics with limited resources to fully adopt antimicrobial stewardship programs (ASP). Following the protocol&#x02019;s introduction, there was an improvement in guideline-concordant prescribing practices. Although the reduction in inappropriate prescriptions (12.6%) did not reach statistical significance during the study&#x02019;s short duration, the numerical decrease suggests that such interventions can positively influence prescribing behavior. In a similar study conducted in an urgent care setting, Lee et al. (2022) observed significant improvements after implementing outpatient antimicrobial stewardship guidelines [<xref rid="B20-pharmacy-13-00030" ref-type="bibr">20</xref>]. Their intervention, which included provider education and pocket guides, increased guideline-concordant prescribing from 50% to 70% (<italic toggle="yes">p</italic> &#x0003c; 0.001) and reduced the duration of antibiotic prescriptions for UTIs from 7 days to 5 days (<italic toggle="yes">p</italic> = 0.007). These findings align with our hypothesis, suggesting that targeted interventions, even with minimal resources, can enhance antibiotic stewardship. Extending the duration of our study could provide a clearer understanding of the long-term benefits, but the observed results underscore the potential role of algorithm-driven protocols in improving prescribing practices in resource-limited settings.</p><p>While prescribing practices for urinary tract infections (UTIs) improved, discrepancies persisted in guideline adherence for upper respiratory infections (URIs) and sexually transmitted infections (STIs). These results suggest that while the intervention was beneficial for certain conditions, targeted, condition-specific strategies may be necessary to align prescribing practices with recommended guidelines across all infectious disease categories. The small sample size and short study duration likely limited our ability to fully observe the intervention&#x02019;s impact.</p><sec id="sec4dot1-pharmacy-13-00030"><title>4.1. Implications for Public Health</title><p>Our study is significant as it contributes to the growing body of literature on antimicrobial stewardship in rural primary care settings. It also emphasizes the vital role primary care practices play in influencing the rate of AMR through their antibiotic prescribing practices. Yau et al. (2021), in their narrative review, collated evidence of the correlations between prescribing patterns in rural primary care centers and increased AMR. For instance, azithromycin use was associated with nasal carriage of <italic toggle="yes">S. pneumoniae</italic> and <italic toggle="yes">S. aureus</italic> strains resistant to macrolides [<xref rid="B21-pharmacy-13-00030" ref-type="bibr">21</xref>,<xref rid="B22-pharmacy-13-00030" ref-type="bibr">22</xref>,<xref rid="B23-pharmacy-13-00030" ref-type="bibr">23</xref>]. Similarly, Hare et al. identified a dose&#x02013;response relationship between azithromycin use and the carriage of macrolide-resistant <italic toggle="yes">S. pneumoniae</italic> and <italic toggle="yes">S. aureus</italic> [<xref rid="B22-pharmacy-13-00030" ref-type="bibr">22</xref>]. Furthermore, Costelloe et al. emphasized this connection, demonstrating that multiple or prolonged antibiotic courses, particularly with amoxicillin and trimethoprim, are linked to higher AMR rates [<xref rid="B21-pharmacy-13-00030" ref-type="bibr">21</xref>,<xref rid="B24-pharmacy-13-00030" ref-type="bibr">24</xref>]. These findings underscore the urgent need for optimized antibiotic stewardship in rural primary care settings to reduce AMR and preserve the efficacy of treatments.</p><p>Implementing antibiotic stewardship programs (ASPs) in rural or underserved communities offers a valuable opportunity to reduce the spread of antibiotic-resistant organisms. Our experience provides a practical model for ASP implementation in resource-limited settings, demonstrating that even small-scale interventions can drive meaningful changes. With sustained efforts, we anticipate that this tailored approach will prove both sustainable and impactful in improving antimicrobial use in such settings.</p></sec><sec id="sec4dot2-pharmacy-13-00030"><title>4.2. Strengths and Limitations</title><p>The strength of our study lies in the use of evidence-based, algorithm-driven strategies tailored to the unique needs of a resource-limited clinic. However, our findings must be interpreted in light of the study&#x02019;s limitations, including the small sample size and short duration, which may have contributed to the lack of statistically significant differences observed, potentially leading to a type II error. These factors limit the generalizability of our results. Additionally, the inherent limitations of the pre&#x02013;post study design, such as its inability to account for unmeasured confounding variables or external events that may have influenced outcomes during the study period, further impact the robustness of our findings. However, given the constraints of our setting, the pre&#x02013;post design was the most practical choice to ensure inclusivity and avoid excluding individuals. Despite these limitations, our study provides meaningful insights for those aiming to implement and adapt ASPs in rural or resource-constrained environments, contributing to the broader understanding of effective strategies to address antimicrobial resistance in these settings.</p></sec><sec id="sec4dot3-pharmacy-13-00030"><title>4.3. Future Directions</title><p>In this study, we did not assess the appropriateness of antibiotic selection but focused solely on evaluating the concordance of prescribed antibiotics with clinical guidelines based on the documented diagnosis. Future studies will aim to evaluate the effect of the algorithm on the appropriateness of antibiotic selection. As we continue this study, we will further refine our intervention to improve antibiotic prescribing practices and document the number of providers who used the simplified algorithm in practice through survey. We anticipate that as we extend the study&#x02019;s duration and increase the sample size, we will be able to more effectively evaluate the long-term outcomes and the sustainability of the intervention. Additionally, as this current study does not have a control group, future studies should consider conducting cluster analyses involving multiple rural clinics, with some clinics implementing an educational intervention (with the algorithm) while others serve as controls. Our overarching goal is to enhance the implementation and effectiveness of ASPs in resource-limited clinics.</p></sec></sec><sec sec-type="conclusions" id="sec5-pharmacy-13-00030"><title>5. Conclusions</title><p>This pilot study demonstrates the potential of algorithm-driven antibiotic stewardship protocols in rural and underserved settings. While the observed improvement in guideline-concordant prescribing practices was promising, further research with larger sample sizes and longer study periods is necessary to confirm these findings. Our experience underscores the importance of implementing ASPs tailored to the unique needs of resource-limited settings, with the potential to significantly impact antimicrobial resistance on a broader scale.</p></sec></body><back><ack><title>Acknowledgments</title><p>Additionally, we express our appreciation to the staff, pharmacists and healthcare providers at Community Health Northwest Florida who made the implementation of the antibiotic stewardship program possible.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-pharmacy-13-00030"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at <uri xlink:href="https://www.mdpi.com/article/10.3390/pharmacy13010030/s1">https://www.mdpi.com/article/10.3390/pharmacy13010030/s1</uri>: simplified antibiotic prescribing algorithm.</p><supplementary-material id="pharmacy-13-00030-s001" position="float" content-type="local-data"><media xlink:href="pharmacy-13-00030-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>A.N.O.: Conceptualization, methodology, project administration, writing&#x02014;original draft preparation, writing&#x02014;review and editing; A.R.P.: investigation, data curation; S.S.: data curation, formal analysis, writing&#x02014;review and editing; P.T.E.: formal analysis, writing&#x02014;review and editing. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The Florida Agricultural and Mechanical University Institutional Review Board has approved this study, and this submission has received Expedited Review based on applicable federal regulations. The initial approval date was 2 July 2019 (reference 052-19) and the subsequent approval date was on 10 January 2024, reference 105-23.</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from all subjects involved in the study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data will be made available upon reasonable request following the institutional applicable guidelines and approvals.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmacy-13-00030"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>US Centers for Disease Control and Prevention</collab>
<collab>US Department of Health and Human Services</collab>
</person-group><source>Antibiotic Resistance Threats in the United States</source><publisher-name>US Centers for Disease Control and Prevention</publisher-name><publisher-loc>Atlanta, GA, USA</publisher-loc><year>2019</year><comment>Available online: <ext-link xlink:href="https://www.cdc.gov/antimicrobial-resistance/data-research/threats/index.html" ext-link-type="uri">https://www.cdc.gov/antimicrobial-resistance/data-research/threats/index.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-10">(accessed on 10 January 2025)</date-in-citation></element-citation></ref><ref id="B2-pharmacy-13-00030"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fleming-Dutra</surname><given-names>K.E.</given-names></name>
<name><surname>Hersh</surname><given-names>A.L.</given-names></name>
<name><surname>Shapiro</surname><given-names>D.J.</given-names></name>
<name><surname>Bartoces</surname><given-names>M.</given-names></name>
<name><surname>Enns</surname><given-names>E.A.</given-names></name>
<name><surname>File</surname><given-names>T.M.</given-names><suffix>Jr.</suffix></name>
<name><surname>Finkelstein</surname><given-names>J.A.</given-names></name>
<name><surname>Gerber</surname><given-names>J.S.</given-names></name>
<name><surname>Hyun</surname><given-names>D.Y.</given-names></name>
<name><surname>Linder</surname><given-names>J.A.</given-names></name>
<etal/>
</person-group><article-title>Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010&#x02013;2011</article-title><source>JAMA</source><year>2016</year><volume>315</volume><fpage>1864</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.4151</pub-id><pub-id pub-id-type="pmid">27139059</pub-id>
</element-citation></ref><ref id="B3-pharmacy-13-00030"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ray</surname><given-names>M.J.</given-names></name>
<name><surname>Tallman</surname><given-names>G.B.</given-names></name>
<name><surname>Bearden</surname><given-names>D.T.</given-names></name>
<name><surname>Elman</surname><given-names>M.R.</given-names></name>
<name><surname>McGregor</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Antibiotic prescribing without documented indication in ambulatory care clinics: National cross sectional study</article-title><source>BMJ</source><year>2019</year><volume>367</volume><fpage>l6461</fpage><pub-id pub-id-type="doi">10.1136/bmj.l6461</pub-id><pub-id pub-id-type="pmid">31826860</pub-id>
</element-citation></ref><ref id="B4-pharmacy-13-00030"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palms</surname><given-names>D.L.</given-names></name>
<name><surname>Hicks</surname><given-names>L.A.</given-names></name>
<name><surname>Bartoces</surname><given-names>M.</given-names></name>
<name><surname>Hersh</surname><given-names>A.L.</given-names></name>
<name><surname>Zetts</surname><given-names>R.</given-names></name>
<name><surname>Hyun</surname><given-names>D.Y.</given-names></name>
<name><surname>Fleming-Dutra</surname><given-names>K.E.</given-names></name>
</person-group><article-title>Comparison of antibiotic prescribing in retail clinics, urgent care centers, emergency departments, and traditional ambulatory care settings in the United States</article-title><source>JAMA Intern. Med.</source><year>2018</year><volume>178</volume><fpage>1267</fpage><lpage>1269</lpage><!--<pub-id pub-id-type="pmcid">PMC6142958</pub-id>--><pub-id pub-id-type="doi">10.1001/jamainternmed.2018.1632</pub-id><pub-id pub-id-type="pmid">30014128</pub-id>
</element-citation></ref><ref id="B5-pharmacy-13-00030"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giles</surname><given-names>A.B.</given-names></name>
<name><surname>Sarbacker</surname><given-names>G.B.</given-names></name>
<name><surname>Anderson</surname><given-names>K.</given-names></name>
<name><surname>King</surname><given-names>C.</given-names></name>
<name><surname>Goodbar</surname><given-names>N.</given-names></name>
<name><surname>Shealy</surname><given-names>K.</given-names></name>
</person-group><article-title>Evaluation of Antibiotic Utilization in a Rural, Outpatient Clinic: An Antimicrobial Stewardship Initiative</article-title><source>J. Pharm. Pract.</source><year>2021</year><volume>34</volume><fpage>703</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1177/0897190019896498</pub-id><pub-id pub-id-type="pmid">31884876</pub-id>
</element-citation></ref><ref id="B6-pharmacy-13-00030"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Staub</surname><given-names>M.B.</given-names></name>
<name><surname>Ouedraogo</surname><given-names>Y.</given-names></name>
<name><surname>Evans</surname><given-names>C.D.</given-names></name>
<name><surname>Katz</surname><given-names>S.E.</given-names></name>
<name><surname>Talley</surname><given-names>P.P.</given-names></name>
<name><surname>Kainer</surname><given-names>M.A.</given-names></name>
<name><surname>Nelson</surname><given-names>G.E.</given-names></name>
</person-group><article-title>Analysis of a high-prescribing state&#x02019;s 2016 outpatient antibiotic prescriptions: Implications for outpatient antimicrobial stewardship interventions</article-title><source>Infect. Control. Hosp. Epidemiol.</source><year>2020</year><volume>41</volume><fpage>135</fpage><lpage>142</lpage><!--<pub-id pub-id-type="pmcid">PMC7309961</pub-id>--><pub-id pub-id-type="doi">10.1017/ice.2019.315</pub-id><pub-id pub-id-type="pmid">31755401</pub-id>
</element-citation></ref><ref id="B7-pharmacy-13-00030"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Drekonja</surname><given-names>D.M.</given-names></name>
<name><surname>Filice</surname><given-names>G.A.</given-names></name>
<name><surname>Greer</surname><given-names>N.</given-names></name>
<name><surname>Olson</surname><given-names>A.</given-names></name>
<name><surname>MacDonald</surname><given-names>R.</given-names></name>
<name><surname>Rutks</surname><given-names>I.</given-names></name>
<name><surname>Wilt</surname><given-names>T.J.</given-names></name>
</person-group><article-title>Antimicrobial stewardship in outpatient settings: A systematic review</article-title><source>Infect. Control. Hosp. Epidemiol.</source><year>2015</year><volume>36</volume><fpage>142</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1017/ice.2014.41</pub-id><pub-id pub-id-type="pmid">25632996</pub-id>
</element-citation></ref><ref id="B8-pharmacy-13-00030"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pekala</surname><given-names>K.R.</given-names></name>
<name><surname>Sharbaugh</surname><given-names>D.</given-names></name>
<name><surname>Yabes</surname><given-names>J.G.</given-names></name>
<name><surname>Sharbaugh</surname><given-names>A.J.</given-names></name>
<name><surname>Yu</surname><given-names>M.</given-names></name>
<name><surname>Grajales</surname><given-names>V.</given-names></name>
<name><surname>Orikogbo</surname><given-names>O.</given-names></name>
<name><surname>Worku</surname><given-names>H.</given-names></name>
<name><surname>Hay</surname><given-names>J.M.</given-names></name>
<name><surname>Zhu</surname><given-names>T.S.</given-names></name>
<etal/>
</person-group><article-title>Implementing Change Through an Outpatient Antibiotic Stewardship Program</article-title><source>Urol. Pract.</source><year>2025</year><volume>12</volume><fpage>82</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1097/UPJ.0000000000000707</pub-id><pub-id pub-id-type="pmid">39264249</pub-id>
</element-citation></ref><ref id="B9-pharmacy-13-00030"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>St Louis</surname><given-names>J.</given-names></name>
<name><surname>Okere</surname><given-names>A.N.</given-names></name>
</person-group><article-title>Clinical impact of pharmacist-led antibiotic stewardship programs in outpatient settings in the United States: A scoping review</article-title><source>Am. J. Health Syst. Pharm.</source><year>2021</year><volume>78</volume><fpage>1426</fpage><lpage>1437</lpage><!--<pub-id pub-id-type="pmcid">PMC8083201</pub-id>--><pub-id pub-id-type="doi">10.1093/ajhp/zxab178</pub-id><pub-id pub-id-type="pmid">33889930</pub-id>
</element-citation></ref><ref id="B10-pharmacy-13-00030"><label>10.</label><element-citation publication-type="webpage"><article-title>CDC&#x02019;s Priority to Address Health Equity Issues Across Antibiotic Resistance</article-title><comment>Available online: <ext-link xlink:href="https://www.iss.it/web/laboratorium-repository/-/cdc-s-priority-to-address-health-equity-issues-across-antibiotic-resistant-threats" ext-link-type="uri">https://www.iss.it/web/laboratorium-repository/-/cdc-s-priority-to-address-health-equity-issues-across-antibiotic-resistant-threats</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-02-18">(accessed on 18 February 2025)</date-in-citation></element-citation></ref><ref id="B11-pharmacy-13-00030"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eudy</surname><given-names>J.L.</given-names></name>
<name><surname>Pallotta</surname><given-names>A.M.</given-names></name>
<name><surname>Neuner</surname><given-names>E.A.</given-names></name>
<name><surname>Brummel</surname><given-names>G.L.</given-names></name>
<name><surname>Postelnick</surname><given-names>M.J.</given-names></name>
<name><surname>Schulz</surname><given-names>L.T.</given-names></name>
<name><surname>Spivak</surname><given-names>E.S.</given-names></name>
<name><surname>Wrenn</surname><given-names>R.H.</given-names></name>
</person-group><article-title>Antimicrobial Stewardship Practice in the Ambulatory Setting from a National Cohort</article-title><source>Open. Forum. Infect. Dis.</source><year>2020</year><volume>7</volume><fpage>ofaa513</fpage><!--<pub-id pub-id-type="pmcid">PMC7686658</pub-id>--><pub-id pub-id-type="doi">10.1093/ofid/ofaa513</pub-id><pub-id pub-id-type="pmid">33269298</pub-id>
</element-citation></ref><ref id="B12-pharmacy-13-00030"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dutcher</surname><given-names>L.</given-names></name>
<name><surname>Degnan</surname><given-names>K.</given-names></name>
<name><surname>Adu-Gyamfi</surname><given-names>A.B.</given-names></name>
<name><surname>Lautenbach</surname><given-names>E.</given-names></name>
<name><surname>Cressman</surname><given-names>L.</given-names></name>
<name><surname>David</surname><given-names>M.Z.</given-names></name>
<name><surname>Cluzet</surname><given-names>V.</given-names></name>
<name><surname>E Szymczak</surname><given-names>J.</given-names></name>
<name><surname>Pegues</surname><given-names>D.A.</given-names></name>
<name><surname>Bilker</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Improving Outpatient Antibiotic Prescribing for Respiratory Tract Infections in Primary Care: A Stepped-Wedge Cluster Randomized Trial</article-title><source>Clin. Infect. Dis.</source><year>2022</year><volume>74</volume><fpage>947</fpage><lpage>956</lpage><!--<pub-id pub-id-type="pmcid">PMC9630878</pub-id>--><pub-id pub-id-type="doi">10.1093/cid/ciab602</pub-id><pub-id pub-id-type="pmid">34212177</pub-id>
</element-citation></ref><ref id="B13-pharmacy-13-00030"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meeker</surname><given-names>D.</given-names></name>
<name><surname>Linder</surname><given-names>J.A.</given-names></name>
<name><surname>Fox</surname><given-names>C.R.</given-names></name>
<name><surname>Friedberg</surname><given-names>M.W.</given-names></name>
<name><surname>Persell</surname><given-names>S.D.</given-names></name>
<name><surname>Goldstein</surname><given-names>N.J.</given-names></name>
<name><surname>Knight</surname><given-names>T.K.</given-names></name>
<name><surname>Hay</surname><given-names>J.W.</given-names></name>
<name><surname>Doctor</surname><given-names>J.N.</given-names></name>
</person-group><article-title>Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial</article-title><source>JAMA</source><year>2016</year><volume>315</volume><fpage>562</fpage><lpage>570</lpage><!--<pub-id pub-id-type="pmcid">PMC6689234</pub-id>--><pub-id pub-id-type="doi">10.1001/jama.2016.0275</pub-id><pub-id pub-id-type="pmid">26864410</pub-id>
</element-citation></ref><ref id="B14-pharmacy-13-00030"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Samore</surname><given-names>M.H.</given-names></name>
<name><surname>Bateman</surname><given-names>K.</given-names></name>
<name><surname>Alder</surname><given-names>S.C.</given-names></name>
<name><surname>Hannah</surname><given-names>E.</given-names></name>
<name><surname>Donnelly</surname><given-names>S.</given-names></name>
<name><surname>Stoddard</surname><given-names>G.J.</given-names></name>
<name><surname>Haddadin</surname><given-names>B.</given-names></name>
<name><surname>Rubin</surname><given-names>M.A.</given-names></name>
<name><surname>Williamson</surname><given-names>J.</given-names></name>
<name><surname>Stults</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Clinical decision support and appropriateness of antimicrobial prescribing: A randomized trial</article-title><source>JAMA</source><year>2005</year><volume>294</volume><fpage>2305</fpage><lpage>2314</lpage><pub-id pub-id-type="doi">10.1001/jama.294.18.2305</pub-id><pub-id pub-id-type="pmid">16278358</pub-id>
</element-citation></ref><ref id="B15-pharmacy-13-00030"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gonzales</surname><given-names>R.</given-names></name>
<name><surname>Anderer</surname><given-names>T.</given-names></name>
<name><surname>McCulloch</surname><given-names>C.E.</given-names></name>
<name><surname>Maselli</surname><given-names>J.H.</given-names></name>
<name><surname>Bloom</surname><given-names>F.J.</given-names><suffix>Jr.</suffix></name>
<name><surname>Graf</surname><given-names>T.R.</given-names></name>
<name><surname>Stahl</surname><given-names>M.</given-names></name>
<name><surname>Yefko</surname><given-names>M.</given-names></name>
<name><surname>Molecavage</surname><given-names>J.</given-names></name>
<name><surname>Metlay</surname><given-names>J.P.</given-names></name>
</person-group><article-title>A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis</article-title><source>JAMA Intern. Med.</source><year>2013</year><volume>173</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2013.1589</pub-id><pub-id pub-id-type="pmid">23319069</pub-id>
</element-citation></ref><ref id="B16-pharmacy-13-00030"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Little</surname><given-names>P.</given-names></name>
<name><surname>Stuart</surname><given-names>B.</given-names></name>
<name><surname>Francis</surname><given-names>N.</given-names></name>
<name><surname>Douglas</surname><given-names>E.</given-names></name>
<name><surname>Tonkin-Crine</surname><given-names>S.</given-names></name>
<name><surname>Anthierens</surname><given-names>S.</given-names></name>
<name><surname>Cals</surname><given-names>J.W.</given-names></name>
<name><surname>Melbye</surname><given-names>H.</given-names></name>
<name><surname>Santer</surname><given-names>M.</given-names></name>
<name><surname>Moore</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: A multinational, cluster, randomised, factorial, controlled trial</article-title><source>Lancet</source><year>2013</year><volume>382</volume><fpage>1175</fpage><lpage>1182</lpage><!--<pub-id pub-id-type="pmcid">PMC3807804</pub-id>--><pub-id pub-id-type="doi">10.1016/S0140-6736(13)60994-0</pub-id><pub-id pub-id-type="pmid">23915885</pub-id>
</element-citation></ref><ref id="B17-pharmacy-13-00030"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nkemdirim Okere</surname><given-names>A.</given-names></name>
<name><surname>Pinto</surname><given-names>A.R.</given-names></name>
<name><surname>Suther</surname><given-names>S.</given-names></name>
</person-group><article-title>A Pilot Study on Understanding the Contextual Factors Impacting the Implementation of Antibiotic Stewardship Program in a Single Health Center Serving Rural and Underserved Communities in the United States&#x02014;A Mixed Method Approach</article-title><source>Preprints</source><year>2025</year><fpage>2025011408</fpage><pub-id pub-id-type="doi">10.20944/preprints202501.1408.v1</pub-id></element-citation></ref><ref id="B18-pharmacy-13-00030"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nkemdirim Okere</surname><given-names>A.</given-names></name>
<name><surname>Pinto</surname><given-names>A.R.</given-names></name>
<name><surname>Suther</surname><given-names>S.</given-names></name>
</person-group><article-title>Knowledge and attitudes of patients in underserved communities regarding antibiotic resistance, antibiotic stewardship, and pharmacist involvement in antibiotic prescribing: A regional survey</article-title><source>Am. J. Health Syst. Pharm.</source><year>2024</year><fpage>zxae341</fpage><pub-id pub-id-type="doi">10.1093/ajhp/zxae341</pub-id><pub-id pub-id-type="pmid">39527071</pub-id>
</element-citation></ref><ref id="B19-pharmacy-13-00030"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nkemdirim Okere</surname><given-names>A.N.</given-names></name>
<name><surname>Trimble</surname><given-names>M.L.</given-names></name>
<name><surname>Sanogo</surname><given-names>V.</given-names></name>
<name><surname>Smith</surname><given-names>U.</given-names></name>
<name><surname>Brown</surname><given-names>C.</given-names></name>
<name><surname>Buxbaum</surname><given-names>S.G.</given-names></name>
</person-group><article-title>The Potential Effects of Implementing an Antibiotic Stewardship Program by Integrating It with Medication Therapy Service in a Low-Income Serving Clinic&#x02014;A Single-Center Experience</article-title><source>Innov. Pharm.</source><year>2022</year><volume>13</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.24926/iip.v13i3.4997</pub-id><pub-id pub-id-type="pmid">36627908</pub-id>
</element-citation></ref><ref id="B20-pharmacy-13-00030"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>P.</given-names></name>
<name><surname>Rico</surname><given-names>M.</given-names></name>
<name><surname>Muench</surname><given-names>S.</given-names></name>
<name><surname>Yost</surname><given-names>C.</given-names></name>
<name><surname>Hall Zimmerman</surname><given-names>L.</given-names></name>
</person-group><article-title>Impact of outpatient antimicrobial stewardship guideline implementation in an urgent care setting</article-title><source>J. Am. Pharm. Assoc. (2003)</source><year>2022</year><volume>62</volume><fpage>1792</fpage><lpage>1798</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2022.06.004</pub-id><pub-id pub-id-type="pmid">35811280</pub-id>
</element-citation></ref><ref id="B21-pharmacy-13-00030"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yau</surname><given-names>J.W.</given-names></name>
<name><surname>Thor</surname><given-names>S.M.</given-names></name>
<name><surname>Tsai</surname><given-names>D.</given-names></name>
<name><surname>Speare</surname><given-names>T.</given-names></name>
<name><surname>Rissel</surname><given-names>C.</given-names></name>
</person-group><article-title>Antimicrobial stewardship in rural and remote primary health care: A narrative review</article-title><source>Antimicrob. Resist. Infect. Control</source><year>2021</year><volume>10</volume><fpage>105</fpage><!--<pub-id pub-id-type="pmcid">PMC8278763</pub-id>--><pub-id pub-id-type="doi">10.1186/s13756-021-00964-1</pub-id><pub-id pub-id-type="pmid">34256853</pub-id>
</element-citation></ref><ref id="B22-pharmacy-13-00030"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hare</surname><given-names>K.M.</given-names></name>
<name><surname>Singleton</surname><given-names>R.J.</given-names></name>
<name><surname>Grimwood</surname><given-names>K.</given-names></name>
<name><surname>Valery</surname><given-names>P.C.</given-names></name>
<name><surname>Cheng</surname><given-names>A.C.</given-names></name>
<name><surname>Morris</surname><given-names>P.S.</given-names></name>
<name><surname>Leach</surname><given-names>A.J.</given-names></name>
<name><surname>Smith-Vaughan</surname><given-names>H.C.</given-names></name>
<name><surname>Chatfield</surname><given-names>M.</given-names></name>
<name><surname>Redding</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e70478</elocation-id><!--<pub-id pub-id-type="pmcid">PMC3734249</pub-id>--><pub-id pub-id-type="doi">10.1371/journal.pone.0070478</pub-id><pub-id pub-id-type="pmid">23940582</pub-id>
</element-citation></ref><ref id="B23-pharmacy-13-00030"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hare</surname><given-names>K.M.</given-names></name>
<name><surname>Grimwood</surname><given-names>K.</given-names></name>
<name><surname>Chang</surname><given-names>A.B.</given-names></name>
<name><surname>Chatfield</surname><given-names>M.D.</given-names></name>
<name><surname>Valery</surname><given-names>P.C.</given-names></name>
<name><surname>Leach</surname><given-names>A.J.</given-names></name>
<name><surname>Smith-Vaughan</surname><given-names>H.C.</given-names></name>
<name><surname>Morris</surname><given-names>P.S.</given-names></name>
<name><surname>Byrnes</surname><given-names>C.A.</given-names></name>
<name><surname>Torzillo</surname><given-names>P.J.</given-names></name>
<etal/>
</person-group><article-title>Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo</article-title><source>Eur. J. Clin. Microbiol. Infect. Dis.</source><year>2015</year><volume>34</volume><fpage>2275</fpage><lpage>2285</lpage><pub-id pub-id-type="doi">10.1007/s10096-015-2480-0</pub-id><pub-id pub-id-type="pmid">26363637</pub-id>
</element-citation></ref><ref id="B24-pharmacy-13-00030"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Costelloe</surname><given-names>C.</given-names></name>
<name><surname>Metcalfe</surname><given-names>C.</given-names></name>
<name><surname>Lovering</surname><given-names>A.</given-names></name>
<name><surname>Mant</surname><given-names>D.</given-names></name>
<name><surname>Hay</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis</article-title><source>BMJ</source><year>2010</year><volume>340</volume><fpage>c2096</fpage><pub-id pub-id-type="doi">10.1136/bmj.c2096</pub-id><pub-id pub-id-type="pmid">20483949</pub-id>
</element-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="pharmacy-13-00030-t001"><object-id pub-id-type="pii">pharmacy-13-00030-t001_Table 1</object-id><label>Table 1</label><caption><p>Adult Study Participants Characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Demographics</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pre-Group (N = 101)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Post-Group (N = 100)</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Female</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77 (76.2%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72 (71.3%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Male</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 (23.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28 (27.7%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Race/Ethnicity</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">African American</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47 (46.5%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46 (45.5%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">White</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41 (40.5%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33 (32.7%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hawaiian</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (2.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hispanic</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (3.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alaskan</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">American Indian</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 (11%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 (13.9%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Age</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18&#x02013;24</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 (17.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 (23.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25&#x02013;34</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33 (32.7%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 (27.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35&#x02013;44</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 (20.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 (15.8%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45&#x02013;54</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 (12.9%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 (18.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55&#x02013;64</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 (11.9%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 (12.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65 and older</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (3.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Insurance</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Private</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33 (32.7%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33 (32.7%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medicare</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (7.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (7.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medicaid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 (27.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 (27.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uninsured</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34 (33.7%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34 (34.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Diagnosis</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlamydia</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 (11.9%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 (8.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlamydia/Trichomonas</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gonorrhea</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (7.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (5.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gonorrhea/Trichomonas</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (2.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trichomonas</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 (16.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 (13.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Syphilis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (3.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (2.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urinary Tract Infection</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 (19.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 (16.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pharyngitis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 (22.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 (24.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sinusitis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 (15.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 (20.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gonorrhea/Chlamydia</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (2.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gonorrhea/Chlamydia/Syphilis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urinary Tract Infection/Trichomonas</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pharyngitis/Trichomonas</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAP</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (2.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upper Respiratory</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (4.0%)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pharmacy-13-00030-t002"><object-id pub-id-type="pii">pharmacy-13-00030-t002_Table 2</object-id><label>Table 2</label><caption><p>The number of patients with at least one prescription that is discordant with clinical guidelines&#x02014;before and after intervention.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Discrepancy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pre-Intervention (N = 101)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Post-Intervention (N = 100)</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>All [Irrespective of diagnosis]</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38 *</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 *</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All&#x02014;Duration</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All&#x02014;Wrong ABX</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All&#x02014;Strength</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All&#x02014;Frequency</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All&#x02014;ABX not recommended</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>UTI (All Patients)</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/20</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4/17</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UTI Duration</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15/20</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3/17</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UTI Wrong ABX</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4/20</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2/17</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UTI Strength</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/20</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/17</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UTI Frequency</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2/20</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/17</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UTI ABX not recommended</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/20</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/17</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>URI (All Patients)</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16/39</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13/49</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">URI Duration</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6/39</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4/49</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">URI Wrong ABX</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4/39</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2/49</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">URI Strength</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/39</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/49</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">URI Frequency</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/39</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/49</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">URI ABX not recommended</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7/39</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6/49</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>STI (All Patients)</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4/35</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7/42</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STI Duration</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3/35</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3/42</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STI Wrong ABX</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/35</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4/42</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STI Strength</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/35</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/42</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STI Frequency</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/35</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/42</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STI ABX not recommended</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/35</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/42</td></tr></tbody></table><table-wrap-foot><fn><p>Note: A single patient may have more than one type of prescription discrepancy. ABX: antibiotics. * (&#x003c7;<sup>2</sup> = 3.72, OR 0.55 [95% CI: 0.30&#x02013;1.01], <italic toggle="yes">p</italic> = 0.054).</p></fn></table-wrap-foot></table-wrap></floats-group></article>